BCS to expand manufacturing of cyclotrons in India, Europe & USA

image credit- shutterstock

Best Cyclotron Systems (BCS), a TeamBest Global Company (TBG), plans to expand its manufacturing operations in India, Europe, and the USA to produce hundreds of cyclotrons annually. Within two years, BCS and TBG will have access to high-energy/high-current 70 MeV and 30 MeV proton beams, as well as 35 MeV alpha, deuteron, and proton multi-particle cyclotrons, and several low-energy proton cyclotrons for theranostics, radiation therapy, research, radioisotope production.

BCS and TBG companies plan to produce the following cyclotrons and ion rapid cycling medical synchrotrons (iRCMS) for research, radioisotope production, theranostics, and for radiation therapy using proton beams from 70 MeV to 250 MeV variable energy and heavy ion therapy up to 400 MeV for carbon - 7.5 MeV, proton beam, B100, self-shielded cyclotron, 9.5 MeV cyclotron, BG-95 for proton beam, self-shielded, 11 MeV, self-shielded, proton beam cyclotron, 15 MeV, high current up to 1000 micro amp current proton beam cyclotron, and 25 MeV proton beam 1000 plus micro amp current cyclotron, 35 MeV adp, and 70 MeV adp alpha deuteron and proton beam cyclotron with 1000 plus micro amp for proton beam and 500 plus micro amp current for deuteron beam and 100 plus micro amp for alpha beam.

In 2024, BCS plans to ship between 10-15 cyclotrons for global customers.